NCT06204016 - Estradiol and Stress Reactivity in Women | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions

Stress vs. ControlEstradiol vs. Placebo

Interventions

DRUG

Estradiol Valerate

To elevate estradiol levels each woman will receive 12mg on two consecutive days (total 24mg) of estradiol valerate (Progynova21©)

DRUG

Placebo

Placebo tablets will be administered as placebo-controlled condition (P-Tabletten White 7mm, Lichtenstein)

Trial Locations (1)

RECRUITING

University of Tuebingen; Department of Psychiatry & Psychotherapy, Tübingen